Article

Topological data analysis identifies distinct biomarker phenotypes during the ‘inflammatory’ phase of COVID-19

2021-12-29

Abstract excerpt

<h4>OBJECTIVES</h4> The relationships between baseline clinical phenotypes and the cytokine milieu of the peak ‘inflammatory’ phase of coronavirus 2019 (COVID-19) are not yet well understood. We used Topological Data Analysis (TDA), a dimensionality reduction technique to identify patterns of inflammation associated with COVID-19 severity and clinical characteristics. <h4>DESIGN</h4> Exploratory analysis from a mu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b118a2c8-229e-50cb-a715-5d7721880b67
DOI: 10.1101/2021.12.25.21268206

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Topological data analysis identifies distinct biomarker phenotypes during the ‘inflammatory’ phase of COVID-19DOI 10.1101/2021.12.25.21268206Read

Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19.Semantic proximity Read

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypesSemantic proximity Read

Identifying COVID-19 phenotypes using cluster analysis and assessing their clinical outcomesSemantic proximity Read

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes.Semantic proximity Read

Longitudinal dynamic clinical phenotypes of in-hospital COVID-19 patients across three dominant virus variants in New York.Semantic proximity Read

Uncovering the Pathophysiological Pattern of Expression from Integrated Analysis across Uniformly Processed RNA Sequencing COVID-19 DatasetsSemantic proximity Read

A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcomeSemantic proximity Read

An immune-protein signature combining TRAIL, IP-10 and CRP for accurate prediction of severe COVID-19 outcomeSemantic proximity Read

The Trans-omics Landscape of COVID-19Semantic proximity Read

Plasma proteomics identify potential severity biomarkers from COVID‐19 associated networkSemantic proximity Read

Clinical Study Protocol of the ‘Biomarkers of Severity of COVID-19 Patients’ (BIOMARCOVID) ProjectSemantic proximity Read

Proteome reveals antiviral host response and NETosis during acute COVID-19 in high-risk patientsSemantic proximity Read